Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Third Harmonic Bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
THRD is no longer listed, so this page shows Q2 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 107
- +7 vs. Q1 2025
- Shares held
- 38.7M
- −25.6K (−0.1%) vs. Q1 2025
- Total value
- $210.2M
- +$75.8M (+56.4%) vs. Q1 2025
- New holders
- 28
- 42 more added
- Sold out
- 21
- 15 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,298,089 | $7.05M | 0.00% | +138,489+11.9% | Added |
| BlackRock, Inc. | 1,726,614 | $9.38M | 0.00% | +246,996+16.7% | Added |
| TCG Crossover Management, LLC | 1,915,424 | $10.4M | 1.19% | −590,000−23.5% | Reduced |
| Nantahala Capital Management, LLC | 2,938,700 | $16.0M | 1.13% | 00.0% | Unchanged |
| BML Capital Management, LLC | 3,824,417 | $20.8M | 15.91% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,779,071 | $31.4M | 0.79% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 10,402,286 | $56.5M | 8.53% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −2,372,933−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −635,150−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −331,800−100.0% | Sold out |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −223,865−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −212,783−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −69,692−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −56,145−100.0% | Sold out |
| O'Brien Greene & Co. Inc | 0 | $0 | 0.00% | −56,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −40,692−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −39,390−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −31,980−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −29,350−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,876−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −14,593−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −10,739−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,574−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3,168−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −123−100.0% | Sold out |